UAE: Emirates Drug Establishment approves oral obesity treatment
Emirates Drug Establishment, EDE UAE, orforglipron, Foundayo, Eli Lilly, oral obesity treatment,…
UAE pharmaceutical sector stable and strategic medicine stockpile secure, Emirates Drug Establishment confirms
UAE’s pharmaceutical sector remains stable with a secure strategic stockpile, ensuring uninterrupted…
UAE Showcases Unified Health Vision at WHX 2026
On the opening day of World Health Expo (WHX) 2026, the Ministry…
Emirates Drug Establishment Recalls Select Nestlé Infant Formula Batches Across UAE Over Safety Concerns
The Emirates Drug Establishment has initiated a precautionary recall of select Nestlé…
Emirates Drug Establishment Approves Tapinarof Cream 1%
Organon, a global healthcare company with a mission to improve the health…
UAE: Statement by H.E. Dr. Fatima Al Kaabi on Commemoration Day
H.E Dr. Fatima Al Kaabi: Commemoration Day is a promise and a…
UAE: EDE recalls “Hong Thai Herbal Inhaler (Yadom)” from local markets due to microbial contamination
The Emirates Drug Establishment (EDE) has ordered the withdrawal of the “Hong…
Emirates Drug Establishment reviews key achievements and future plans
UAE- December 2024 - The Board of Directors of the Emirates Drug…
